SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
FOTIADES GEORGE L

(Last) (First) (Middle)
7000 CARDINAL PLACE

(Street)
DUBLIN OH 43017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President & COO
3. Date of Earliest Transaction (Month/Day/Year)
05/31/2005
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 05/31/2005 M(1) 73,245 A $38.287 153,645 D
Common Shares 05/31/2005 S(1) 73,245 D $57.7695(4) 80,400 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy)(2) $38.287 05/31/2005 M 1 06/01/2001 06/02/2005 Common Shares 73,245 (5) 0 D
Option (right to buy)(3) $41.553 09/16/2001 09/16/2008 Common Shares 56,250 1 D
Option (right to buy)(3) $47.333 03/01/2002 03/01/2009 Common Shares 27,171 1 D
Option (right to buy)(3) $31.167 11/15/2002 11/15/2009 Common Shares 67,907 1 D
Option (right to buy)(3) $66.083 11/20/2003 11/20/2010 Common Shares 60,530 1 D
Option (right to buy)(3) $68.1 11/19/2004 11/19/2011 Common Shares 67,915 1 D
Option (right to buy)(3) $67.9 11/18/2005 11/18/2012 Common Shares 250,000 1 D
Option (right to buy)(3) $64.11 01/31/2007 02/01/2014 Common Shares 225,000 1 D
Explanation of Responses:
1. The exercise and sale reported on this Form 4 were effected pursuant to a 10b5-1 plan established by the reporting person on November 10, 2004, when the reporting person was not aware of material non-public information about the Company. The stock option exercised pursuant to the 10b5-1 plan would have expired on June 2, 2005, if not exercised.
2. Stock option granted pursuant to the R.P. Scherer Stock Option Plan.
3. Stock option granted pursuant to the Cardinal health, Inc. Equity Incentive Plan.
4. Weighted average sale price from 27 different transactions with the price ranging from $57.67 to $57.94. The details of these transactions are as follows: 5,000 shares at $57.67, 100 shares at $57.68, 200 shares at $57.69, 3,000 shares at $57.70, 3,800 shares at $57.71, 2,500 shares at $57.72, 3,900 shares at $57.73, 3,100 shares at $57.74, 16,400 shares at $57.75, 1,600 shares at $57.76, 7,800 shares at $57.77, 700 shares at $57.78, 1,600 shares at $57.79, 1,800 shares at $57.80, 4,100 shares at $57.81, 5,400 shares at $57.82, 600 shares at $57.83, 3,445 shares at $57.84, 900 shares at $57.85, 2,600 shares at $57.86, 2,500 shares at $57.87, 400 shares at $57.88, 600 shares at $57.89, 400 shares at $57.90, 600 shares at $57.91, 100 shares at $57.93 and 100 shares at $57.94.
5. Stock option was disposed of in connection with its exercise for no additional consideration beyond the option shares.
Remarks:
George L. Fotiades 05/31/2005
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.